ARTV · Artiva Biotherapeutics, Inc. · Documents
$4.27
-1.89 (-30.68%)
At close · Oct 27
Return incl. dividend (before tax)
Market Cap
$208.76M
Shares
48.89M
Volume · Oct 27
8.67M
Avg daily vol (3M)
536.31K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Artiva Biotherapeutics halted AlloNK® (AB-101) development following two recent Grade 5 events, is reducing workforce by approximately 94%, and is exploring strategic alternatives; preliminary cash, cash equivalents and investments were approximately $319.1 million as of September 30, 2026. | 2026-10-27 | 2026-10-22 | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 8-K | — | 2026-09-11 | 2026-09-08 | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| S-3 | — | 2026-08-06 | — | |
| 8-K | — | 2026-08-06 | — | |
| ARS | — | 2026-08-03 | 2025-12-31 | |
| DEF 14A | — | 2026-08-03 | 2026-09-08 | |
| 8-K | — | 2026-07-22 | — | |
| Investor Event Transcript | — | 2026-06-30 | — | |
| Investor Event Transcript | — | 2026-06-04 | 2026-06-30 | |
| 8-K | — | 2026-05-19 | 2026-05-18 | |
| 8-K | — | 2026-05-08 | — | |
| 8-K | — | 2026-05-08 | — | |
| 10-Q | — | 2026-05-08 | 2026-03-31 | |
| 10-K/A | — | 2026-04-30 | 2025-12-31 | |
| Investor Event Transcript | — | 2026-04-15 | 2026-06-30 | |
| 8-K | — | 2026-03-10 | — | |
| 10-K | — | 2026-03-10 | 2025-12-31 | |
| 8-K | — | 2026-02-24 | 2026-02-18 | |
| 8-K | — | 2026-02-19 | 2026-02-18 | |
| 8-K | — | 2025-12-12 | 2025-12-10 | |
| 8-K | — | 2025-11-12 | — | |
| 8-K | — | 2025-11-12 | — | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| S-3 | — | 2025-08-06 | — | |
| 8-K | — | 2025-08-06 | — | |
| 8-K | — | 2025-06-25 | 2025-06-24 | |
| 8-K | — | 2025-05-08 | — | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| ARS | — | 2025-04-29 | 2024-12-31 | |
| DEF 14A | — | 2025-04-29 | 2025-06-24 | |
| DEFA14A | — | 2025-04-29 | — | |
| 10-K | — | 2025-03-24 | 2024-12-31 | |
| 8-K | — | 2025-03-24 | — | |
| 8-K | — | 2025-01-29 | 2025-01-28 | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| 8-K | — | 2024-10-22 | 2024-10-21 | |
| 8-K | — | 2024-08-29 | — | |
| 10-Q | — | 2024-08-29 | 2024-06-30 | |
| 8-K | — | 2024-07-22 | — | |
| S-1/A | — | 2024-07-15 | — | |
| S-1 | — | 2024-06-28 | — | |
| S-1/A | — | 2022-06-06 | — | |
| S-1/A | — | 2022-03-07 | — | |
| S-1/A | — | 2022-01-21 | — | |
| S-1/A | — | 2021-12-16 | — | |
| S-1 | — | 2021-04-08 | — |
Showing 1–50 of 50 filings